Not Tagged
Not Tagged
['sclc', 'nsclc']
the main question in neoadjuvant therapy for driver-addicted nsclc remains: those patients have a very good response, but residual disease remains there. and there is no immune system to patrol further in the distance. maybe ami + tkis could be a way to enhance results? #asco23
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.